The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Urethral Stricture Treatment Devices Market Projected To Become By 2030 Based On Its 2026 Valuation?
The urethral stricture treatment devices market size has experienced strong growth in recent years. It is anticipated to increase from $1.47 billion in 2025 to $1.59 billion in 2026, at a compound annual growth rate (CAGR) of 8.0%. This historical expansion can be linked to factors such as a rise in urological disorders, the aging male population, an increase in catheterization procedures, the expansion of hospital urology departments, and surgical stricture treatments.
The urethral stricture treatment devices market size is anticipated to experience substantial growth over the next few years. It is predicted to expand to **$2.14 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.8%.** The projected increase during this period stems from factors such as the growth in minimally invasive urology, the demand for long-term stent solutions, the adoption of advanced biomaterials, the expansion of outpatient procedures, and the emergence of personalized urology devices. Noteworthy trends for the forecast period include minimally invasive stricture management, advancements in balloon dilation technologies, the development of advanced urethral stents, improvements in catheter materials, and an increase in outpatient urology procedures.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20986&type=smp
Which Market Drivers Are Supporting The Expansion Of The Urethral Stricture Treatment Devices Market?
The increasing occurrence of benign prostatic hyperplasia (BPH) and neurogenic bladder is anticipated to boost the urethral stricture treatment devices market in the coming years. BPH, a prevalent condition among older men, involves an enlarged prostate gland that frequently causes urinary obstruction and heightens the likelihood of urethral strictures. The growing incidence of BPH is largely attributable to aging, with men over 50 experiencing a higher rate, while lifestyle, hormonal shifts, and chronic illnesses also contribute to its development. Urethral stricture treatment devices find common application in urological issues like BPH, especially when post-operative issues or extended catheter use result in urethral narrowing, necessitating tools such as dilators, stents, or urethrotomy instruments to restore regular urine flow. For example, a September 2023 report from the Royal Pharmaceutical Society, a UK-based professional body, indicated that approximately 3 million individuals in the UK suffer from BPH, with its incidence at about 50% in males aged 60–70 years and escalating to 90% in males aged over 80 years. Consequently, the increasing prevalence of BPH and neurogenic bladder will propel the urethral stricture treatment device market.
What Segment Groups Are Identified Within The Urethral Stricture Treatment Devices Market?
The urethral stricture treatment devices market covered in this report is segmented –
1) By Product Type: Urethral Dilators, Urethral Stents, Urethral Balloon Dilation Catheters, Urinary Catheters
2) By Stricture Location: Anterior, Posterior
3) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Urethral Dilators: Semi-Rigid Urethral Dilators, Flexible Urethral Dilators, Balloon Urethral Dilators, Graded Urethral Dilators
2) By Urethral Stents: Self-Expanding Urethral Stents, Balloon-Expandable Urethral Stents, Metallic Urethral Stents, Silicone Urethral Stents
3) By Urethral Balloon Dilation Catheters: Single-Balloon Dilation Catheters, Double-Balloon Dilation Catheters, Coaxial Balloon Dilation Catheters, Hydrophilic-Coated Balloon Dilation Catheters
4) By Urinary Catheters: Foley Urinary Catheters, Intermittent Urinary Catheters, External Urinary Catheters, Supra-Pubic Urinary Catheters
What Trends Are Advancing Progress In The Urethral Stricture Treatment Devices Market?
Leading companies in the urethral stricture treatment devices market are increasingly adopting a strategic partnership model to improve technology integration and broaden their market reach. A strategic partnership denotes a collaborative relationship between two or more entities where they pool their resources, expertise, and efforts to achieve shared goals. For example, in April 2024, Laborie Medical Technologies Corp., a US-based diagnostic and therapeutic medical technology company, collaborated with the NHS Specialized Services Device Programme (SSDP) to incorporate its Optilume Urethral Drug-Coated Balloon (DCB) into the program. This partnership guarantees reimbursement for NHS hospitals in England, thus broadening patient access to this innovative device. Optilume integrates balloon dilation with anti-proliferative drug delivery to decrease the recurrence of urethral strictures. This minimally invasive technology offers a transformative alternative to traditional surgery or repeated treatments, addressing a crucial need within the urology community.
Which Companies Hold Significant Positions In The Urethral Stricture Treatment Devices Market?
Major companies operating in the urethral stricture treatment devices market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, Medline Industries LP., Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, B. Braun SE, Olympus Corporation, Coloplast Ltd, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Medical, ConvaTec Inc., Ambu A/S, Richard Wolf GmbH, Laborie Medical Technologies, Bactiguard AB, UROMED Kurt Drews KG, Pnn Medical A/S, Hydrumedical SA, Allium Ltd., Med pro Medical B.V., Urotronic Inc., Rocamed SAM, Zhejiang ChuangXiang Medical Technology Co. Ltd
Read the full urethral stricture treatment devices market report here:
How Is The Urethral Stricture Treatment Devices Market Distributed Across Key Geographic Regions?
North America was the largest region in the urethral stricture treatment devices market in 2025. The regions covered in the urethral stricture treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Urethral Stricture Treatment Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20986&type=smp
Browse Through More Reports Similar to the Global Urethral Stricture Treatment Devices Market 2026, By The Business Research Company
Bath And Shower Products Market Report 2026
https://www.thebusinessresearchcompany.com/report/bath-and-shower-products-global-market-report
Urology Surgical Instruments Market Report 2026
https://www.thebusinessresearchcompany.com/report/urology-surgical-instruments-global-market-report
Urinary Stone Treatment Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model